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Mills GD, Harris DM, Chen X, Houser SR. Intracellular sodium determines frequency-dependent alterations in contractility in hypertrophied feline ventricular myocytes. Am J Physiol Heart Circ Physiol 292: H1129 -H1138, 2007. First published September 29, 2006 ; doi:10.1152/ajpheart.00375.2006.-Hypertrophy and failure (H/F) in humans and large mammals are characterized by a change from a positive developed force-frequency relationship (ϩFFR) in normal myocardium to a flattened or negative developed force-frequency relationship (ϪFFR) in disease. Altered Ca 2ϩ homeostasis underlies this process, but the role of intracellular Na ϩ concentration ([Na ϩ ]i) in H/F and frequency-dependent contractility reserve is unclear. We hypothesized that altered [Na ϩ ]i is central to the ϪFFR response in H/F feline myocytes. Aortic constriction caused left ventricular hypertrophy (LVH). We found that as pacing rate was increased, contraction magnitude was maintained in isolated control myocytes (CM) but decreased in LVH myocytes (LVH-M). Quiescent LVH-M had higher [Na ϩ ]i than CM (LVH-M 13.3 Ϯ 0.3 vs. CM 8.9 Ϯ 0.2 mmol/l; P Ͻ 0.001) with 0.5-Hz pacing (LVH-M 14.9 Ϯ 0.5 vs. CM 10.8 Ϯ 0.4 mmol/l; P Ͻ 0.001) but were not different at 2.5 Hz (17.0 Ϯ 0.7 vs. control 16.0 Ϯ 0.7 mmol/l; not significant). [Na ϩ ]i was altered by patch pipette dialysis to define the effect of [Na ϩ ]i on contraction magnitude and action potential (AP) wave shape at slow and fast pacing rates. Using AP clamp, we showed that LVH-M require increased [Na ϩ ]i and long diastolic intervals to maintain normal shortening. Finally, we determined the voltage dependence of contraction for Ca 2ϩ current (ICa)-triggered and Na ϩ /Ca 2ϩ exchangermediated contractions and showed that there is a greater [Na ϩ ]i dependence of contractility in LVH-M. These data show that increased [Na ϩ ]i is essential for maintaining contractility at slow heart rates but contributes to small contractions at fast rates unless ratedependent AP shortening is prevented, suggesting that altered [Na ϩ ]i regulation is a critical contributor to abnormal contractility in disease. cardiac function; calcium handing CHRONIC, PROGRESSIVE HEMODYNAMIC stress, as occurs in aortic stenosis, induces cardiac hypertrophy and a modified ventricular myocyte contractile phenotype that can lead to depressed cardiac function and cardiac decompensation. Altered myocyte contractility and its cellular and molecular bases have been described in the hypertrophied/failing (H/F) heart (15) . Initially, there is a slowing of relaxation with maintenance of systolic performance, but systolic performance is eventually compromised (22) . A characteristic contractile alteration in the H/F heart of large mammals, including humans, is a change from an increase in contractility with increased rate (ϩforce-frequency relationship, ϩFFR) in the normal heart to a decrease in contractility with increased rate (Ϫforce-frequency relationship, ϪFFR) in the failing heart (27) . While the cellular determinants of altered dynamic contractility have been studied, they are not well understood and are the major topic of this study.
Rate-dependent increases in the filling of sarcoplasmic reticulum (SR) Ca 2ϩ stores are abnormal in myocytes from the failing human heart and in muscles and myocytes from other large mammalian models of H/F (13, 17, 20) . A reduction in the abundance and/or activity of the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) has been linked to these contractility changes (28, 29, 32) . We recently showed (32) that in human heart failure (HF), contractility in failing myocardium is actually greater than in nonfailing myocardium at very slow pacing rates. However, there was a significant increase in isometric force in nonfailing muscles and a significant decrease in force in failing muscles as the pacing rate was increased. How H/F myocytes with depressed SR function maintain a high contractility at slow heart rates, but then are subsequently unable to further increase their contractility when heart rate increases, is not well explained by reduced SR function alone. In the present study, we examined the hypothesis that alterations in myocyte intracellular Na ϩ concentration ([Na ϩ ] i ) regulation are central to the maintenance of normal contractility of H/F myocytes at slow pacing rates and contribute to the ϪFFR characteristic of this model.
A number of previous studies have shown that [Na ϩ ] i is greater than normal in failing myocardium (32) . The causes for this change in myocyte Na ϩ metabolism are still not clear, but some evidence for increased Na ϩ influx as well as reduced Na ϩ -K ϩ -ATPase activity or abundance has been reported (10, 24 ] i via the NCX, and this provides a source of Ca 2ϩ to enhance SR Ca 2ϩ loading. Therefore, alterations in [Na ϩ ] i have important effects on cardiac contractility. Indeed, this is the well-known mechanism of action of cardiac glycosides, which increase myocyte Ca 2ϩ through inhibition of the Na ϩ -K ϩ -ATPase and subsequent effects on the NCX (30) . The contribution of altered [Na ϩ ] i to abnormal contractility in the H/F myocyte has not been fully established, partly because there are simultaneous alterations in action potentials (AP) wave shape, Ca 2ϩ current (I Ca ) density, Ca 2ϩ regulatory protein abundance, and phosphorylation in the failing heart, and each factor has effects on contractility. In this study, we explored the independent role of alterations in [Na ϩ ] i in basal and frequency-dependent contractility defects in a well-char-acterized feline model of H/F. We (15, 26) 
METHODS
Aortic banding. Progressive pressure overload (PO) was induced by aortic constriction in 10 mongrel cats as previously described (4). All animal work was done with the approval and under the supervision of the Temple University School of Medicine Institutional Animal Care and Use Committee. Briefly, at 6 -8 wk of age (0.9 -1.1 kg), animals were sedated with ketamine and acepromazine (35 mg/kg and 0.5 mg/kg), intubated, and maintained on 1.0% isoflurane and 100% O 2. Through a right thoracotomy at the third or fourth intercostal space, the pericardium was entered and a fixed, stationary band (12-mm circumference) was placed on the ascending aorta. This technique causes modest PO initially. However, as the animals grow, the band causes slow, progressive PO. Animals were banded for 6 -12 wk after characterization of cardiac geometry and contractile function with transthoracic echocardiography.
Myocyte isolation. Left ventricular myocytes were isolated as previously described (34) . After being washed with Krebs solution (in mmol/l: 12.5 glucose, 5.4 KCl, 1.0 lactic acid, 1.2 magnesium sulfate, 130 NaCl, 1.2 sodium phosphate, 2.5 sodium bicarbonate, 2.0 sodium pyruvate, pH 7.4) containing 1% (wt/vol) BSA, 10 mmol/l taurine, and 0.20 mmol/l CaCl 2, cells were kept at room temperature with 5% CO2 blowby and used within 6 h of isolation. All experiments were performed on single rod-shaped myocytes with clear sarcomeric cross striations. Na ϩ fluorescence measurement and calibration. [Na ϩ ]i was measured with the cell-permeant, sodium-sensitive fluorophore sodiumbinding benzofuran isophthalate (SBFI; Molecular Probes, Eugene, OR). Cells were suspended in with normal Tyrode solution (in mmol/l: 150 NaCl, 5 HEPES, 2 Na-pyruvate, 5.4 KCl, 1.2 magnesium chloride, pH 7.4) with 1 mmol/l CaCl 2 and loaded with 10 mol/l SBFI-AM for 90 min at room temperature in the presence of the nonionic surfactant Pluronic F-127 (0.05% wt/vol). The cells were then transferred to a 37°C water-jacketed chamber mounted on the stage of an inverted microscope (Zeiss Axiovert 10, Thornwood, NY), and perfused with normal Tyrode solution for 20 min to deesterify the fluorescence probe. Fluorescence was elicited by illumination with a 75-W xenon lamp filtered to obtain dual excitation measurements (340 and 380 nm, F 340 and F380) with a Lambda 10B optical filter changer (Sutter Instruments, Novato, CA) at 4 Hz. Emitted light was filtered to 525 nm (filter set XF04 -2, Omega Optical, Brattleboro, VT) and recorded at each excitation wavelength, and a ratio was obtained (F 340/F380). Cells were visualized at high magnification, and contractions were briefly elicited with field stimulation. Fluorescence recordings were then obtained while cells were quiescent for 5-10 min and while they were being paced at 0.5 and 2.5 Hz.
Calibration of SBFI was accomplished by exposing each myocyte to 0, 10, and 20 mmol/l extracellular Na ϩ concentration ([Na ϩ ]o) in the presence of 10 mol/l gramicidin D and 100 mol/l strophanthidin, as described previously (9) . Two solutions of equal ionic strength were prepared, one containing 145 mmol/l Na ϩ (30 mmol/l NaCl and 115 mmol/l sodium gluconate) with no K ϩ and the other containing 145 mmol/l K ϩ (30 mmol/l KCl and 115 mmol/l potassium gluconate) with no Na ϩ . Both contained (in mmol/l) 10 HEPES, 10 glucose, and 2 EGTA (pH 7.2, adjusted with Tris base). These were mixed to prepare the final calibration solutions. Cells were exposed to 0, 10, and 20 mmol/l [Na ϩ ]o for 15, 10, and 10 min, respectively, or until the fluorescence signal was stable.
Cell physiology. Suction-type patch pipettes were prepared from borosilicate glass (1B150F, World Precision Instruments, Sarasota, FL) with a two-stage pipette puller (model P-87, Sutter Instruments, Novato, CA). The pipette tip was heat polished before use and had a tip resistance of 2-5 M⍀. The pipette was attached to a patch-clamp amplifier (Axoclamp II, Axon Instruments, Foster City, CA). Cells were studied at 37°C and were perfused with normal Tyrode solution (in mmol/l: 150 NaCl, 5 HEPES, 2 Na-pyruvate, 5.4 KCl, 1.2 magnesium chloride, pH 7.4) with 1 mmol/l CaCl2.
The perforated patch technique was used where noted to gain electrical access to the cell and induce contraction, minimizing cell dialysis (8) . The pipette solution contained (in mmol/l) 10 HEPES, 110 potassium aspartate, 5 dipotassium-ATP, 0.001 Tris-GTP, 2 magnesium chloride, 20 potassium chloride, 10 sodium chloride, 1 calcium chloride, and amphotericin B (240 g/ml in DMSO), pH 7.2 with potassium hydroxide. Amphotericin B formed aqueous channels in the cell membrane, permitting electrical access to the cell while preventing the dialysis of cellular components that could alter cell function. After seal formation, increases in the capacitive current response to a Ϫ10-mV step were monitored to determine cellular access (3-5 min). To initiate action potentials, a square current pulse was applied at 1.0 Hz. Contractions were recorded by video edge detection (VED-104, Crescent Electronics, Sandy, UT). pCLAMP 8.2 software (Axon Instruments) was used for data acquisition and analysis.
To obtain AP recordings and induce contraction, the ruptured-patch technique was used to gain electrical access to the cell (8) . Three pipette solutions were used to dialyze cells with 0, 10, or 20 mmol/l Na ϩ ([Na ϩ ]pip). All solutions contained (in mmol/l) 10 HEPES, 110 potassium aspartate, 5 dipotassium-ATP, 0.001 Tris-GTP, 2 magnesium chloride, 20 potassium chloride, and 0 NaCl-20 N-methyl-Dglucamine (NMDG), 10 NaCl-10 NMDG, or 20 NaCl-0 NMDG to maintain ionic balance. Cells were randomly assigned to each group, and cells from each animal were included in each sodium group. After high-resistance seal formation was obtained, the patch was ruptured and the pipette solution was allowed to dialyze for 10 min. APs were initiated with a square current pulse was applied at 0.5 and 2.5 Hz for 5 min each. Contractions were recorded by video edge detection (VED-104, Crescent Electronics). pCLAMP 8.2 software (Axon Instruments) was used for data acquisition and analysis.
The AP voltage-clamp technique was used to study AP duration (APD)-independent effects of rate on contractility. A command voltage profile was modeled after a 250-ms AP recorded from a representative control feline left ventricular (LV) myocyte under perforatedpatch (nondialyzed) conditions. Pipette filling solutions and dialysis protocols used were identical to those in the AP recording protocol described above. Current recordings and contractions were recorded during the AP clamp step at 0.5 and 2.5 Hz. Subsequently, each cell was tested with 250-ms square depolarizing steps to Ϫ30 to ϩ70 mV from a holding potential of Ϫ40 mV, and early peak and late plateau currents and contractions were recorded to approximate the voltage sensitivity of whole cell Ca 2ϩ current, whole cell NCX current, and contraction.
Statistical methods. All data are presented as means Ϯ SE. Statistical difference between the mean values for two groups was evaluated with paired or unpaired Student's t-test, and two-way ANOVA was used to determine the effects of multiple factors on the overall variance within a data set. Post hoc analyses of individual group comparisons were performed with the Bonferroni posttest method. Values of P Ͻ 0.05 were considered significant.
RESULTS
Aortic constriction (banding) causes an increase in LV thickness (anterolateral wall of LV: 0.61 Ϯ 0.04 cm vs. control 0.44 Ϯ 0.04 cm; P Ͻ 0.05) and end-diastolic LV (1.42 Ϯ 0.07 cm vs. control 1.31 Ϯ 0.06 cm; not significant) and peak systolic LV (0.82 Ϯ 0.09 cm vs. control 0.64 Ϯ 0.02 cm; P Ͻ 0.05) chamber diameter with, on average, preserved baseline (resting) contractility (fractional area change ratio derived from 2-dimensional images of the LV chamber area during diastole and systole: 0.59 Ϯ 0.04 vs. control 0.65 Ϯ 0.04; not significant) as evaluated by transthoracic echocardiography. This model was further characterized in a previous study from this laboratory (21) . Most animals had compensated LV hypertrophy (LVH) based on the absence of clinical signs of HF (shortness of breath with exertion and pulmonary effusions or ascites at death), but four animals, with large end-diastolic chamber dimensions, exhibited these signs of early HF. This model represents a continuum of severe hypertrophy and early HF. Myocytes from all of these animals were used in the experiments described below. Banded animals had an increased heart weight-to-body weight ratio of 9.0 Ϯ 0.9 vs. control (4.1 Ϯ 0.5).
Rate-dependent fractional shortening. The frequency dependence of LV myocyte contractility was measured in LVH myocytes (LVH-M) and control myocytes (CM). These studies were performed with perforated patch techniques to minimize cellular dialysis and preserve the native intracellular environment. Contractions were measured immediately after gaining electrical access to the cell. Fractional shortening (FS) was not significantly different at 0.5 Hz [ Fig. 1B ; LVH-M 9.1 Ϯ 1.4% vs. CM 7.5 Ϯ 1.1% resting cell length (RCL); n ϭ 8 in each group]. As pacing rate was increased, contraction magnitude was maintained in CM but decreased significantly in LVH-M [1.5 Hz: 9.0 Ϯ 1.0 vs. 5.7 Ϯ 0.8% RCL (P Ͻ 0.05); 2.0 Hz: 8.6 Ϯ 1.0 vs. 5.3 Ϯ 0.8% RCL (P Ͻ 0.05); 2.5 Hz: 9.3 Ϯ 1.4 vs. 5.2 Ϯ 0.5% RCL (P Ͻ 0.05)]. These experiments document that feline LVH-M (exhibiting a spectrum of severe hypertrophy and early HF) have a fundamental contractility defect similar to that observed in the failing human heart and animal models with less severe disease (10, 28) . We next investigated the role of altered [Na ϩ ] i regulation in the ϪFFR. In these experiments, myocytes were paced at 0.5 and 2.5 Hz to explore the limits of the frequency ranges that can be routinely used in feline myocytes.
[Na ϩ ] i in quiescent and paced LV myocytes. [Na ϩ ] i was measured in LVH-M and CM with the Na ϩ -fluorescent dye SBFI. After 20 min of deesterification and dye washout, fluorescence was recorded at 340 and 380 nm in quiescent (nonpaced) myocytes until SBFI fluorescence reached a steady state. Myocytes were then paced at 0.5 and 2.5 Hz (Fig. 2, A and B, show representative F 340 -to-F 380 ratios from CM and LVH-M). Every cell was then calibrated with bath solutions with 0, 10, and 20 mmol/l Na ϩ with the Na ϩ ionophore gramicidin D and the Na ϩ pump inhibitor strophanthidin. Quiescent LVH-M had significantly higher [Na ] i is significantly elevated in LVH-M at slow pacing rates, but the greater increase in [Na ϩ ] i with rate in CM is such that there are no significant differences between groups at fast pacing rates. The role of these differences in rate-dependent changes in myocyte contractility was next studied by controlling [Na ϩ ] i with cellular dialysis through low-resistance pipettes.
Effect (Fig. 3A) . Two-way ANOVA comparing the contribution of group (LVH-M vs. CM) and [Na ϩ ] pip with the overall data variability was significant (P Ͻ 0.01 for both ] pip ) at both rates. Post hoc analysis showed that shortening was significantly greater in CM dialyzed with 20 mmol/l Na ϩ compared with CM dialyzed with 0 mmol/l Na ϩ (7.1 Ϯ 0.4 vs. 4.3 Ϯ 0.4% RCL, P Ͻ 0.01; n ϭ 28 and 36, respectively) and greater than LVH-M dialyzed with 20 mmol/l Na ϩ (5.2 Ϯ 0.6% RCL, P Ͻ 0.01; n ϭ 18). There was no statistical difference between CM and LVH-M at slow pacing rates. In experiments with 20 mmol/l [Na ϩ ] pip , CM maintained contractility as pacing rate was increased, while myocyte shortening decreased significantly in LVH-M when pacing rate was increased. This is similar to the results observed in undialyzed myocytes.
Duration of contraction (or relaxation time) was measured as the time from the stimulus to the time when contraction recovered to 50% maximum FS (Fig. 3B) . In both groups (LVH-M and CM), stimulation rate had a significant effect on the time to 50% relaxation (P Ͻ 0.05), but there was no effect of [Na APD, the time from stimulus to 75% repolarization, was measured in each group (Fig. 3D) ] pip . Cells from control and banded animals from all groups at slow and fast pacing rates were stimulated with the same 250-ms (APD75%) AP waveform derived from a control myocyte stimulated at an average (1.5 Hz) pacing rate with perforated patch (i.e., with Relaxation time was also measured in cells dialyzed with 0, 10, and 20 mmol/l [Na ϩ ] pip at low and high pacing rates (Fig.  4C ). There was a small, but insignificant, increase in the time to 50% relaxation with increasing [Na ϩ ] pip in CM at both pacing rates, with high rate causing shorter contractions. Twoway ANOVA revealed a significant effect of both group (control vs. banded, P Ͻ 0.01) and [Na dependent and sometimes contradictory, the available data support the idea that [Na ϩ ] i is elevated in these disease states (36) . In addition, there is extensive literature examining alterations in Na ϩ influx and efflux pathways in H/F that support the idea that [Na ϩ ] i would consequentially be increased. Studies in normal myocardium have shown that increasing [Na ϩ ] i causes increased SR load but also alters the timing of SR loading such that long diastolic intervals are necessary to maintain SR load, resulting in a negative force-frequency response (19) . This latter effect is compounded by the shortened APs caused by high [Na ϩ ] i (23) . There is little information concerning the effect of altering [Na ϩ ] i on myocyte contractile function in the context of hypertrophy and HF. Therefore, while it is known that [Na ϩ ] i is an important modulator of cardiac function, its role in disease is unclear and was the topic of this study.
In the present investigation, we studied the role of altered ] i compared with control by 63% and 47%, respectively (2, 9). However, another study with pacing-induced HF in rabbits showed a small decrease from 5.2 to 4.4 mmol/l [Na ϩ ] i with disease (38) . In dogs, atrioventricular block-induced hypertrophy (AVB) caused [Na ϩ ] i to increase from 3.2 to 7.9 mmol/l. [Na ϩ ] i has also been measured in hypertrophied human myocardial sections with Na ϩ -sensitive microelectrodes and was shown to be elevated compared with control myocardium taken from patients undergoing mitral valve repair (14.2 vs. 11.9 mmol/l) (14) . Finally, a study done in collaboration with our laboratory found elevated [Na ϩ ] i in paced failing human myocytes and papillary muscles by two separate methods (28) ] i , there is a defect in FS that is reversed when the APD is normalized by AP clamp. These data suggest that the adaptive effect of [Na ϩ ] i on contractility at high pacing rates is offset by rate-dependent AP shortening.
In summary, our study shows that [Na ϩ ] i is elevated in LVM isolated from pressure-overloaded feline myocytes and that this alteration is an important adaptive mechanism to support contractions at slow heart rates but may limit contractility at high heart rates. Further investigations will be necessary to study the complex role of the NCX in this model of hypertrophy and early HF.
